Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,640 | 1,190 | 1,360 | 1,480 | 2,670 |
| TOTAL | $1,640 | $1,190 | $1,360 | $1,480 | $2,670 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,040 | 1,030 | 1,050 | 780 |
| Other Non-Current Assets | 10,500 | 10,790 | 10,870 | 12,940 | 13,390 |
| TOTAL | $10,500 | $11,830 | $11,900 | $13,990 | $14,170 |
| Total Assets | $12,140 | $13,020 | $13,260 | $15,470 | $16,840 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 80 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 7,940 | 8,490 | 10,830 | 11,240 | 10,900 |
| Other current liabilities | 0 | 80 | 80 | 80 | 80 |
| TOTAL | $8,020 | $8,570 | $10,910 | $11,320 | $10,980 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,010 | 1,060 | 2,280 | 4,430 | 5,460 |
| TOTAL | $1,010 | $1,060 | $2,280 | $4,430 | $5,460 |
| Total Liabilities | $9,030 | $9,630 | $13,190 | $15,750 | $16,440 |
| Shareholders' Equity | |||||
| Common Shares | 350 | 350 | 350 | 290 | 290 |
| Other shareholders' equity | 40 | 40 | 40 | 30 | 30 |
| TOTAL | $473,420 | $473,030 | $472,910 | $466,240 | $465,790 |
| Total Liabilities And Equity | $482,450 | $482,660 | $486,100 | $481,990 | $482,230 |